Search in:

Upsala Journal of Medical Sciences Volume 124, 2019 - Issue 1: Uppsala Clinical Research Center - World-leading support for clinical sciences. Guest edited by Lars Berglund, Stefan James, and Johan Sundström

Journal homepage

Open access

3,402

Views

CrossRef citations to date

Altmetric

Article

Effects of DAPAgliflozin on CARDiac substrate uptake, myocardial efficiency, and myocardial contractile work in type 2 diabetes patients—a description of the DAPACARD study

Axel ÅkerblomUppsala Clinical Research Center and Department of Medical Sciences, Uppsala University, Uppsala, Sweden; Correspondence[email protected]
View further author information

Jonas OldgrenUppsala Clinical Research Center and Department of Medical Sciences, Uppsala University, Uppsala, Sweden; View further author information

Aino Latva-RaskuTurku PET Centre, University of Turku, Turku, Finland; ;Department of endocrinology, Turku University Hospital, Turku, Finland; View further author information

Lars JohanssonAntaros Medical AB, Gothenburg, Sweden; View further author information

Vera LisovskajaAstraZeneca, Gothenburg, SwedenView further author information

Cecilia KarlssonAstraZeneca, Gothenburg, SwedenView further author information

Jan OscarssonAstraZeneca, Gothenburg, SwedenView further author information

Pirjo NuutilaTurku PET Centre, University of Turku, Turku, Finland; ;Department of endocrinology, Turku University Hospital, Turku, Finland; View further author information

show all

Pages 59-64 | Received 21 Jun 2018, Accepted 13 Aug 2018, Published online: 08 Jan 2019

Cite this article
https://doi.org/10.1080/03009734.2018.1515281
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (13)

Huiliao He, Tingting Tang, Xiaohua Wang, Lingling Zhou & Liang Wang. (2023) Comparing endoscopic ultrasonography and double contrast-enhanced ultrasonography in the preoperative diagnosis of gastric stromal tumor. Cancer Imaging 23:1.
Crossref

Fereshte Attaran, Sepideh Emami, Masoudreza Sohrabi, Mojtaba Malek, Hossein Ajdarkosh, Mahmoodreza Khoonsari, Faramarz Ismail-Beigi & Mohammad E. Khamseh. (2023) Effect of Empagliflozin and Pioglitazone on left ventricular function in patients with type two diabetes and nonalcoholic fatty liver disease without established cardiovascular disease: a randomized single-blind clinical trial. BMC Gastroenterology 23:1.
Crossref

Vincenzo RussoMarco Malvezzi Caracciolo D’AquinoAlfredo CaturanoGabriella ScognamiglioEnrica PezzulloDario FabianiCarmen Del GiudiceAndreina CarboneRoberta BottinoValentina CasoGerardo NigroPaolo GolinoBiagio LiccardoAntonello D’Andrea. (2023) Improvement of global longitudinal strain and myocardial work in type 2 diabetes patients on sodium-glucose cotransporter 2 inhibitors therapy. Journal of Cardiovascular Pharmacology.
Crossref

Ioannis Paraskevaidis, Andrew Xanthopoulos, Nikolaos Karamichalakis, Filippos Triposkiadis & Elias Tsougos. (2023) Medical Treatment in Heart Failure with Reduced Ejection Fraction: A Proposed Algorithm Based on the Patient’s Electrolytes and Congestion Status. Medical Sciences 11:2, pages 38.
Crossref

He Sun, Zhongqing Wang, Yuxi Wang, Haichuan Rong, Danyang Wang, Xiangnian Liu, Ke Jin, Zhicheng Sun & Qiuling Fan. (2023) Bibliometric and visualized analysis of sodium–Glucose cotransporter 2 inhibitors. Frontiers in Pharmacology 13.
Crossref

Hongtao Yu, Sanchita Basu, Weifeng Tang, Robert C. Penland, Peter J. Greasley, Jan Oscarsson, David W. Boulton & K. Melissa Hallow. (2022) Predicted Cardiac Functional Responses to Renal Actions of SGLT2i in the DAPACARD Trial Population: A Mathematical Modeling Analysis. The Journal of Clinical Pharmacology 62:4, pages 541-554.
Crossref

Jonas Oldgren, Sanna Laurila, Axel Åkerblom, Aino Latva‐Rasku, Eleni Rebelos, Henrik Isackson, Maria Saarenhovi, Olof Eriksson, Kerstin Heurling, Edvin Johansson, Ulrica Wilderäng, Cecilia Karlsson, Russell Esterline, Ele Ferrannini, Jan Oscarsson & Pirjo Nuutila. (2021) Effects of 6 weeks of treatment with dapagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: A randomized, placebo‐controlled, exploratory study. Diabetes, Obesity and Metabolism 23:7, pages 1505-1517.
Crossref

Melanie Nana, Holly Morgan & L. N. Rao Bondugulapati. (2020) Sodium-glucose co-transporter 2 inhibitors and heart failure—the present and the future. Heart Failure Reviews 26:4, pages 953-960.
Crossref

Amir Fathi, Keeran Vickneson & Jagdeep S. Singh. (2020) SGLT2-inhibitors; more than just glycosuria and diuresis. Heart Failure Reviews 26:3, pages 623-642.
Crossref

Hidekazu Tanaka, Kazuhiro Tatsumi, Hiroki Matsuzoe, Kensuke Matsumoto & Ken-ichi Hirata. (2020) Impact of diabetes mellitus on left ventricular longitudinal function of patients with non-ischemic dilated cardiomyopathy. Cardiovascular Diabetology 19:1.
Crossref

Giuseppe Rosano, David Quek & Felipe Martínez. (2020) Sodium–Glucose Co-transporter 2 Inhibitors in Heart Failure: Recent Data and Implications for Practice. Cardiac Failure Review 6.
Crossref

Jessica Reid, Khyatiben Rana, Stephanie Niman, Mae Sheikh-Ali, Todd Lewis, Rushab R. Choksi & Rebecca F. Goldfaden. (2020) Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors for Cardiovascular Disease Prevention. American Journal of Cardiovascular Drugs 20:5, pages 419-429.
Crossref

Dulce Brito, Paulo Bettencourt, Davide Carvalho, Jorge Ferreira, Ricardo Fontes-Carvalho, Fátima Franco, Brenda Moura, José Carlos Silva-Cardoso, Rachel Tavares de Melo & Cândida Fonseca. (2020) Sodium-Glucose Co-transporter 2 Inhibitors in the Failing Heart: a Growing Potential. Cardiovascular Drugs and Therapy 34:3, pages 419-436.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Effects of DAPAgliflozin on CARDiac substrate uptake, myocardial efficiency, and myocardial contractile work in type 2 diabetes patients—a description of the DAPACARD study

Articles from other publishers (13)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Effects of DAPAgliflozin on CARDiac substrate uptake, myocardial efficiency, and myocardial contractile work in type 2 diabetes patients—a description of the DAPACARD study

Citations (13)

Articles from other publishers (13)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date